{"version":"1.0","provider_name":"Lymphoma Clinical Research Studies\u2013EPCORE Program","provider_url":"https:\/\/epcore-trials.com\/es-us\/","author_name":"ctmabbvieepcor","author_url":"https:\/\/epcore-trials.com\/es-us\/author\/ctmabbvieepcor\/","title":"Estudio EPCORE NHL-5 - Lymphoma Clinical Research Studies\u2013EPCORE Program","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"BDZkQcBNJ3\"><a href=\"https:\/\/epcore-trials.com\/es-us\/nhl-5\/\">Estudio EPCORE NHL-5<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/epcore-trials.com\/es-us\/nhl-5\/embed\/#?secret=BDZkQcBNJ3\" width=\"600\" height=\"338\" title=\"&#8220;Estudio EPCORE NHL-5&#8221; &#8212; Lymphoma Clinical Research Studies\u2013EPCORE Program\" data-secret=\"BDZkQcBNJ3\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/epcore-trials.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/epcore-trials.com\/wp-content\/uploads\/2022\/08\/AbbVie_EPCORE_NHL-5_Concept_Photo_FINAL.jpg","thumbnail_width":1440,"thumbnail_height":932,"description":"Acerca delestudio EPCORE NHL-5 El estudio EPCORE NHL-5 est\u00e1 evaluando la seguridad y la tolerabilidad de un medicamento principal en fase de investigaci\u00f3n en combinaci\u00f3n con otros medicamentos para adultos con linfoma no Hodgkin (NHL). El estudio est\u00e1 dirigido para aquellas personas que tienen tipos espec\u00edficos de NHL recurrente, refractario o no tratado previamente. No [&hellip;]"}